HLA-Ig Based Artificial Antigen Presenting Cells: Efficient Expansion-Human CTL l Protocol Preview

aAPC Mediated Activation and Expansion of Natural Killer T Cells | Protocol PreviewПодробнее

KaAPC for Efficient Depletion of Antigen-specific T Cells | Protocol PreviewПодробнее

Towards personalized manufacturing of T Cells with artificial antigen presenting cells and AIПодробнее

Antigen presentation: HLA genes and MHC II receptors What is the difference?Подробнее

Surface and Intracellular Antigen Analyses of Neural Cell Types by FC | Protocol PreviewПодробнее

Exogenous Pathway of Antigen Presentation | MHC II ProcessingПодробнее

Antigen Presentation: MHC Class I vs. MHC Class IIПодробнее

SB and Artificial Antigen Presenting Cells in GM-T Cells: Application | Protocol PreviewПодробнее

Antigen-specific T Cells Expansion with Magnetic Nanoparticles | Protocol PreviewПодробнее

Development: Cell-Type Specific Anti-HIV gp120 Aptamers For siRNA Delivery l Protocol PreviewПодробнее

HLA Class II Antigen PresentationПодробнее

HMGB1 Protein Role in Helix Distorting, Site-specific DNA ICLs | Protocol PreviewПодробнее

Hepatocyte-Like Cells From Human Embryonic Stem Cell Populations l Protocol PreviewПодробнее

Spliceosomal snRNA Localization in Hela Cells by Microinjection | Protocol PreviewПодробнее

B-cell lymphoma 2 mediated regulation protects growth plate cartilageПодробнее

Medical vocabulary: What does HLA-A2 Antigen meanПодробнее

Introducing the HLA Assay as a Companion Diagnostic in Immunotherapy DevelopmentПодробнее

Peptide-MHC-I Tetramer Staining for Analysis of SIV T cells | Protocol PreviewПодробнее

STAT115 Chapter 26.2 HLA and Neoantigen PresentationПодробнее